Cypress Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cypress Wealth Advisors's BMY Position: Q1 2019 in Review
Cypress Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.45% in Q1 2019, selling an estimated $6.67K and leaving 29,456 shares worth $1.41M. The position accounts for 1.61% of the portfolio, ranked #23.
Cypress Wealth Advisors first reported a position in BMY in Q2 2015 and has held it in 16 quarters since. The position peaked at $2.48M in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.
- Cypress Wealth Advisors held 29,456 shares of Bristol-Myers Squibb worth $1.41M as of Q1 2019.
- Cypress Wealth Advisors sold 134 Bristol-Myers Squibb shares in Q1 2019, an estimated $6.67K.
- Bristol-Myers Squibb made up 1.61% of Cypress Wealth Advisors's portfolio in Q1 2019, its #23 holding.
- Cypress Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 16 quarters since.
- Cypress Wealth Advisors's Bristol-Myers Squibb position peaked at $2.48M in Q2 2016.
- 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.
Based on Cypress Wealth Advisors's 13F filing for Q1 2019, filed 17 May 2019.